Table 2.

Individual patient's characteristics describing the age, sex, primary site involved, histopathological subtype, and metastatic involvement of lung or any other site.

Patient no.	Age (y)	Sex	Primary site	Subtype	Lung mets	Other sites
1	48	F	Rt Humerus	N/A	P	N/I
2	16	M	Rt Tibia	MMT	P	N/I
3	13	F	Rt Femur	N/A	N	N/I
4	17	M	Rt Humerus	N/A	P	N/I
5	13	M	Rt Femur	N/A	P	N/I
6	24	M	Rt Chest wall	N/A	N	N/I
7	14	M	Lt Femur	CDB	N	N/I
8	24	M	Rt Femur	N/A	P	N/I
9	66	M	Rt Femur	N/A	P	N/I
10	19	M	Rt Femur	Osteoclastic type	P	Left scapula
11	14	F	Lt Clavicle	CDB	N	N/I
12	25	M	Rt Femur	Spindle cells with necrosis Osteoid+	N	N/I
13	28	F	Lt Humerus	MMT	N	N/I
14	11	M	Lt Femur	MMT	N	N/I
15	35	F	Lt Tibia	MMT	P	N/I
16	8	F	Lt Femur	N/A	P	N/I
17	8	F	Rt Femur	N/A	P	N/I
18	24	M	Lt Femur	N/A	N	N/I
19	16	M	Lt Tibia	N/A	N	N/I
20	10	F	Lt Fibula	N/A	N	N/I
21	17	M	Lt Fibula	MMT	N	N/I
22	24	M	Rt Jaw	Spindle cells (freq. mitosis and high labelling index, MIB-I)	N	N/I

F: female, M: male, Rt: right, Lt: left, N/A: not available, CDB: chondroblastic differentiation, MMT: malignant mesenchymal tumor, P: positive, N: negative, N/I: not involved.